In patients with schizophrenia, there appear to be connections between longer duration of illness, raised levels of eotaxin, decreased telomere length, reduced gray matter volume, and impaired episodic memory.

file_download Download in HQ

Related content

description Article
The Use of Virtual Reality in the Treatment of Severe Mental Illnesses: The Example of Psychosis

The use of virtual reality in the treatment of severe mental illnesses

02.10.2024 Schizophrenia
Diagnostic Challenges in Bipolar Disorder: Depression, Mania, and Schizophrenia play_circle Video play_circle
Diagnostic Challenges in Bipolar Disorder: Depression, Mania, and Schizophrenia

In this video, Professors Lakshmi Yatham, MD., and Christoph Correll, MD. discuss the challenges of differentiating bipolar disorder.

03.09.2024 Bipolar Disorder
Novel and emerging pharmacologic treatments for Schizophrenia play_circle Video play_circle
Novel and emerging pharmacologic treatments for Schizophrenia

In this video Professor Christoph Correll discusses the challenges with available schizophrenia treatments & what clinicians should keep in mind when considering the emerging treatment options for schizophrenia.

14.11.2023 Schizophrenia